FdaApplication
ANDA 204876
Identifiers
- fda_app_no: ANDA204876
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2017-07-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BIVALIRUDIN | BIVALIRUDIN | 250MG/VIAL | INJECTABLE;INTRAVENOUS |
1 product